Wednesday May 27, 2020 – 10am EST/ 4pm CET
Cambrex will be hosting a live webinar on understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays and we would like to invite you to join us.
Dr Craig Callahan, Project Scientist, Cambrex Edinburgh
Crystallization is often the ultimate step of a drug substance manufacturing process prior to isolation and drying. A robust crystallization process can allow many benefits, such as isolation of a desired polymorphic form, optimization of purity through exclusion of impurities, and enhanced yield. Additionally, a crystallization process can allow physical properties of a batch of particles to be optimized. An API’s particle size distribution, particle morphology and flow properties can also have a significant impact on the downstream processing that it will have to endure en-route to a formulated drug product. Filtration, washing, drying and formulation can all be enhanced, and product consistency improved, by adopting a suitable, well developed crystallization process that targets suitable particles by design.
Cambrex’s Edinburgh site is a world-leader in providing solid form development services for drug substance and drug product.